Literature reviews serve as an indispensable cornerstone in the rigorous landscape of drug development, providing the critical evidence base necessary…
Read More
Rubedo Life Sciences Charts Ambitious Course to Reverse Skin Aging and Disease Through Targeted Senescent Cell Clearance
In a significant pivot from the traditional aesthetics market, Rubedo Life Sciences, under the leadership of CEO Dr. Frederick Beddingfield…
Read More
JAMA study finds moderate caffeine intake tracks with lower dementia risk, provides adenosine-pathway nudge for drug hunters
A landmark prospective cohort study, published online on February 9, 2026, in the esteemed journal JAMA, has unveiled a compelling…
Read More
Evogene, Systasy and LMU University Hospital Munich team up on AI-driven drug discovery for inflammatory diseases
A groundbreaking international collaboration, fortified by a prestigious pan-European EUREKA grant, has been officially launched to pioneer the development of…
Read More
Closing the Information Gap: ETH Zürich Team Integrates Function and Binding in One Drug Screening Assay
A groundbreaking development from a collaborative team at ETH Zurich and Karolinska Institutet promises to revolutionize early-stage drug discovery by…
Read More
Can live cell dynamics fix drug discovery’s efficacy problem?
The pharmaceutical industry faces an escalating crisis marked by soaring costs, protracted timelines, and persistently low success rates in bringing…
Read More
Terray says TerraBind delivers 26x faster inference than Boltz-2 by skipping diffusion-based coordinate generation
Terray Therapeutics, a burgeoning startup based in the Los Angeles area, has unveiled TerraBind, a groundbreaking potency prediction model designed…
Read More
From List Price to Net Price: How Finance Leaders Decode Real Drug Costs
In the intricate landscape of the healthcare industry, the discourse surrounding drug pricing frequently fixates on the list price. Public…
Read More
How digital tools and AI are accelerating drug discovery
The pharmaceutical industry stands at a critical juncture, grappling with escalating costs and protracted timelines in the arduous journey of…
Read More
FDA Refuses to Review Moderna’s mRNA Flu Vaccine Application, Citing Comparator Study Design
Washington D.C. – Moderna, a leading biotechnology company, has announced that the U.S. Food and Drug Administration (FDA) has issued…
Read MoreYOU MAY HAVE MISSED
